Sign in
MDS-572 Continuous Transfusion Independence With Imetelstat in Heavily Transfused Non-Del(5q) Lower-Risk Myelodysplastic Neoplasms Relapsed/Refractory/Ineligible for Erythropoiesis-Stimulating Agents in IMerge Phase III
Journal article   Peer reviewed

MDS-572 Continuous Transfusion Independence With Imetelstat in Heavily Transfused Non-Del(5q) Lower-Risk Myelodysplastic Neoplasms Relapsed/Refractory/Ineligible for Erythropoiesis-Stimulating Agents in IMerge Phase III

Uwe Platzbecker, Valeria Santini, Pierre Fenaux, Mikkael Sekeres, Michael Savona, Yazan Madanat, Maria Diez-Campelo, David Valcárcel-Ferreiras, Thomas Illmer, Anna JonáŠová, …
Clinical lymphoma, myeloma and leukemia, Vol.23, pp.S371-S371
2023-09

Metrics

1 Record Views

Details